Tashkent, Uzbekistan (UzDaily.com) -- Uzbekistan has temporarily banned the sale of the Indian drug for flu and colds Doc-1 Max. This was stated in the Agency for the Development of the Pharmaceutical Industry of Uzbekistan.

The Agency noted that there were reports on social networks about the side effects of the drug.

The agency said in a statement that the Agency for the Development of the Pharmaceutical Industry of Uzbekistan, after the appearance of information on social networks, took the situation under control.

To study the condition of patients and determine the causes of the incident, a special group of experts was formed.

The tablets and syrups with lemon and honey flavor purchased in Samarkand pharmacies from the Indian company Marion Biotech Pvt are now undergoing examination. The results of the study will be made public after the completion of laboratory analysis.